The 35th CINP World Congress of Neuropsychopharmacology

講演情報

[CINP2024] Short Communications

CINP2024 » Short Communications

Short Communications 18
Others 1

2024年5月25日(土) 13:00 〜 14:15 Room 9 (G404)

Chair: Hiroko Kotajima (Tokyo Metropolitan Institute of Medical Science)

[SC18-6] Methoxphenidine, a designer drug or a possible route for research to depression treatment?

*Bronislav Jurásek1, Magdalena Vágnerová1,2, Hana Walaská1, Kristýna Mazochová3, Martin Kuchař1 (1. Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of chemistry and technology in Prague, Prague, Czech Republic, 2. Department of Analytical Chemistry, University of chemistry and technology in Prague, Prague, Czech Republic, 3. Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic)

キーワード:Methoxphenidine, Dissociative anaesthetics, Antidepressant, Pharmacokinetics

抄録パスワード認証
抄録の閲覧にはパスワードが必要です。パスワードを入力して認証してください。

パスワード